Rothschild Investment Corp Adaptive Biotechnologies Corp Transaction History
Rothschild Investment Corp
- $1.19 Billion
- Q3 2023
A detailed history of Rothschild Investment Corp transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Rothschild Investment Corp holds 10,000 shares of ADPT stock, worth $100,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$100,300% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding ADPT
# of Institutions
239Shares Held
152MCall Options Held
23.6KPut Options Held
37.7K-
Viking Global Investors LP30MShares$301 Million0.61% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$132 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$117 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$112 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.73MShares$77.6 Million0.62% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.43B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...